<table><tr><th>From:</th><th>Steven Sinofsky</th></tr><tr><td>Sent:</td><td>Wednesday, November 1, 2017 4:33 PM</td></tr><tr><td>To:</td><td>Jeffrey E.</td></tr><tr><td>Subject:</td><td>Re:</td></tr></table>

Yes no problem. but will be=tomorrow. London for PA's shindig.

On No= 1, 2017, at 4:31PM, Jeffrey E. <jeevacation@gmail.com <mailto:jeevacation@gmail.co=> > wrote:

s=eve can you give some guidance

On Wed, Nov 1, 2017 at 12:20 PM, Masha Drokova
wrote:

I'm looking to invest at the company doing AI-based glucose moni=oring system for people with diabetes. We made tech evaluation, talke= to a few experts and more a question about the market and regulations. Lik=ly no, because it's complex area, but still thinking of them. </=pan>

May be s=meone in your network who knows this area and can advise on this kind of te=h?

Center Health
Deck: <=pan>https://drive.google.com/file/d/0B5O93D3IJArEb=BsdII4elVob0U/view
<https://drive.google.com/file/d/0B5O93D3IJArEbXBsdII4elVob0U= target=> 
<=ont face="Roboto-Regular">

Our memo: https://docs.google.com/document/d/1M7ZV7VEI8CTnb4Et=WFH2sq5dcCm0PM6g1AlcwrlOtM <https://d=cs.google.com/document/d/1M7ZV7VEI8CTnb4EtYWFH2sq5dcCm0PM6g1AlcwrlOtM> =span>

Center Health&nbs=;is building an Al-based glucose monitoring system for the 1 in 1= Americans who suffer from diabetes, based on machine learning and their pe=sonalized AI, Aria. Users subscribe to their disposable test strips, a=$14B/yr US market, which are delivered monthly, as Aria learns about their d=abetes and prompts behavioral changes to lower blood sugar. The s=stem is an order of magnitude cheaper than existing technologies, premised o= leveraging data to help users see what daily elements are affecting t=eir blood sugar, and predicting dangerous highs and lows before they happen=

## Pros

— Existing glucome=ers from big companies are very old-fashioned and outdated, those companies=make their revenue from overpriced strips

— Direct com=etitors, such as iHealth and Dario have negative customer revie=s and minor

— Uses FDA-approved circuits to get the approval i= an automated manner

## Pros (cont.)

Cons

— Enormous pressure both from the industry players and companies s=ch as Apple and Google that try to develop non-invasive glucose monitoring t=at will wipe out test strip products

— Hardware startu= without a product to sell yet, finalizing the development

?=80? Young team
<=div>

&=bsp; please note

The information contained in this communicat=on is confidential, may be attorney-client privileged, may constitute=inside information, and is intended only for the use of the addressee. 1= is the property of

JEE

Unauthorized use, disclosure or copying of th=s communication or any part thereof is strictly prohibited and may be=unlawful. If you have received this communication in error, please notif= us immediately by return e-mail or by e-mail to jeevacation@gmail.com <mailto:jeeva=ation@gmail.com> , and destro= this communication and all copies thereof, including all attachments. c=pyright -all rights reserved